GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art
Nauck, Michael A., Quast, Daniel R., Wefers, Jakob, Meier, Juris J.
Published in Molecular metabolism (Germany) (01.04.2021)
Published in Molecular metabolism (Germany) (01.04.2021)
Get full text
Journal Article
Treatment of type 2 diabetes: challenges, hopes, and anticipated successes
Nauck, Michael A, Wefers, Jakob, Meier, Juris J
Published in The lancet. Diabetes & endocrinology (01.08.2021)
Published in The lancet. Diabetes & endocrinology (01.08.2021)
Get full text
Journal Article
Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial
Pratley, Richard, Amod, Aslam, Hoff, Søren Tetens, Kadowaki, Takashi, Lingvay, Ildiko, Nauck, Michael, Pedersen, Karen Boje, Saugstrup, Trine, Meier, Juris J
Published in The Lancet (British edition) (06.07.2019)
Published in The Lancet (British edition) (06.07.2019)
Get full text
Journal Article
Heart failure and type 2 diabetes: From cardiovascular outcome trials, with hope
Giugliano, Dario, Meier, Juris J., Esposito, Katherine
Published in Diabetes, obesity & metabolism (01.05.2019)
Published in Diabetes, obesity & metabolism (01.05.2019)
Get full text
Journal Article
Role of Reduced β-Cell Mass Versus Impaired β-Cell Function in the Pathogenesis of Type 2 Diabetes
Get full text
Conference Proceeding
Journal Article
Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors
Nauck, Michael A, Meier, Juris J, Cavender, Matthew A, Abd El Aziz, Mirna, Drucker, Daniel J
Published in Circulation (New York, N.Y.) (29.08.2017)
Published in Circulation (New York, N.Y.) (29.08.2017)
Get full text
Journal Article
Incretin‐based glucose‐lowering medications and the risk of acute pancreatitis and malignancies: a meta‐analysis based on cardiovascular outcomes trials
Abd El Aziz, Mirna, Cahyadi, Oscar, Meier, Juris J., Schmidt, Wolfgang E., Nauck, Michael A.
Published in Diabetes, obesity & metabolism (01.04.2020)
Published in Diabetes, obesity & metabolism (01.04.2020)
Get full text
Journal Article
Occurrence of nausea, vomiting and diarrhoea reported as adverse events in clinical trials studying glucagon‐like peptide‐1 receptor agonists: A systematic analysis of published clinical trials
Bettge, Karolin, Kahle, Melanie, Abd El Aziz, Mirna S., Meier, Juris J., Nauck, Michael A.
Published in Diabetes, obesity & metabolism (01.03.2017)
Published in Diabetes, obesity & metabolism (01.03.2017)
Get full text
Journal Article
A meta‐analysis comparing clinical effects of short‐ or long‐acting GLP‐1 receptor agonists versus insulin treatment from head‐to‐head studies in type 2 diabetic patients
Abd El Aziz, Mirna S., Kahle, Melanie, Meier, Juris J., Nauck, Michael A.
Published in Diabetes, obesity & metabolism (01.02.2017)
Published in Diabetes, obesity & metabolism (01.02.2017)
Get full text
Journal Article
Rapid Tachyphylaxis of the Glucagon-Like Peptide 1-Induced Deceleration of Gastric Emptying in Humans
NAUCK, Michael A, KEMMERIES, Guido, HOLST, Jens J, MEIER, Juris J
Published in Diabetes (New York, N.Y.) (01.05.2011)
Published in Diabetes (New York, N.Y.) (01.05.2011)
Get full text
Journal Article